Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.
Timothy Coon, Wilna J Moree, Binfeng Li, Jinghua Yu, Said Zamani-Kord, Siobhan Malany, Mark A Santos, Lisa M Hernandez, Robert E Petroski, Aixia Sun, Jenny Wen, Sue Sullivan, Jason Haelewyn, Michael Hedrick, Samuel J Hoare, Margaret J Bradbury, Paul D Crowe, Graham Beaton
Index: Bioorg. Med. Chem. Lett. 19(15) , 4380-4, (2009)
Full Text: HTML
Abstract
The benzimidazole core of the selective non-brain-penetrating H(1)-antihistamine mizolastine was used to identify a series of brain-penetrating H(1)-antihistamines for the potential treatment of insomnia. Using cassette PK studies, brain-penetrating H(1)-antihistamines were identified and in vivo efficacy was demonstrated in a rat EEG/EMG model. Further optimization focused on strategies to attenuate an identified hERG liability, leading to the discovery of 4i with a promising in vitro profile.
Related Compounds
Related Articles:
Aggregation of 2-aminobenzimidazole--a combined experimental and theoretical investigation.
2011-06-20
[ChemPhysChem 12(9) , 1747-55, (2011)]
2010-03-19
[ACS Chem. Biol. 5 , 287-299, (2010)]
2009-07-01
[Bioorg. Med. Chem. Lett. 19(13) , 3568-72, (2009)]
Synthesis and QSAR studies of novel 1-substituted-2-aminobenzimidazoles derivatives.
2006-09-01
[Eur. J. Med. Chem. 41(9) , 1080-3, (2006)]
2010-05-20
[J. Phys. Chem. B 114(19) , 6608-13, (2010)]